Thompson C J, Ward J M, Hopwood D A
Nature. 1980 Jul 31;286(5772):525-7. doi: 10.1038/286525a0.
The biochemical and morphological differentiation of actinomycetes makes them academically and economically interesting. Their secondary metabolites provide the majority of medically and agriculturally important antibiotics (streptomycete genes may also be the primary source of clinically important antibiotic resistance); their complex morphological developmental cycle involves a series of changes from vegetative mycelial growth to spore formation. Recombinant DNA technology would add a powerful new dimension to the analysis of these various aspects of actinomycete biology and would also facilitate the development of industrial strains with increased antibiotic yield, or capable of making new antibiotics. For most of these purposes, cloning of genes within and between actinomycetes is required to study the expression of particular genes in genetic backgrounds defined by mutations of the characters under study. To achieve this, we have now developed a method for molecular cloning involving the transfer of genes between unrelated streptomycetes.
放线菌的生化和形态分化使其在学术和经济方面都具有重要意义。它们的次级代谢产物提供了大多数医学和农业上重要的抗生素(链霉菌基因也可能是临床上重要抗生素耐药性的主要来源);它们复杂的形态发育周期涉及从营养菌丝生长到孢子形成的一系列变化。重组DNA技术将为放线菌生物学这些不同方面的分析增添一个强大的新维度,也将有助于开发抗生素产量增加或能够产生新抗生素的工业菌株。对于大多数这些目的,需要在放线菌内部和之间克隆基因,以研究特定基因在由所研究性状的突变定义的遗传背景中的表达。为了实现这一点,我们现在已经开发出一种分子克隆方法,该方法涉及在不相关的链霉菌之间转移基因。